1. 1. Llovet JM KRK, Villanueva A et al. (2021) Hepatocellular carcinoma. Nature Reviews Disease Primers, 7(1): 6. [DOI:10.1038/s41572-020-00240-3]

2. Gong XQ TYY, Wu YK et al. (2021) Progress of MRI radiomics in hepatocellular carcinoma. Front Oncol, 11: 698373. [DOI:10.3389/fonc.2021.698373]

3. Hennedige T and Venkatesh SK (2016) Advances in computed tomography and magnetic resonance imaging of hepatocellular carcinoma. World J Gastroenterol, 22(1): 205-20. [DOI:10.3748/wjg.v22.i1.205]

4. Chartampilas ERV, Georgopoulou VKG, Hatzidakis APP (2022) Current imaging diagnosis of hepatocellular carcinoma. Cancers (Basel), 14(16): 3997. [DOI:10.3390/cancers14163997]

5. Dalla Palma L and Pozzi-Mucelli RS (1992) Computed tomography and magnetic resonance imaging in diagnosing hepatocellular carcinoma. Ital J Gastroenterol, 24(2): 87-91.

6. Dai Y, Liu D, Xin Y, et al. (2023) Efficacy and interpretability analysis of noninvasive imaging based on computed tomography in patients with hepatocellular carcinoma after initial transarterial chemoembolization. Acad Radiol, 30 (Suppl 1): S61-S72. [DOI:10.1016/j.acra.2023.05.027]

7. Jiang HY, Chen J, Xia CC, Cao LK, Duan T, Song B (2018) Noninvasive imaging of hepatocellular carcinoma: From diagnosis to prognosis. World J Gastroenterol, 24(22): 2348-2362. [DOI:10.3748/wjg.v24.i22.2348]

8. Fang D YC, Zhou H, et al. (2022) Effects of CT/MRI image fusion on cerebrovascular protection, postoperative complications, and limb functional recovery in patients with anterior and middle skull-base tumors: Based on a retrospective cohort study. Contrast Media Mol Imaging, 2022: 7855576. [DOI:10.1155/2022/7855576]

9. Chen C XLC, Wang Y, et al. (2019) Assessment of the cryoablation margin using MRI-CT fusion imaging in hepatic malignancies. Clin Radiol, 74(8): 652.e21-652.e28. [DOI:10.1016/j.crad.2019.03.021]

10. Zhou H, Yang G, Jing X, et al. (2023) Predictive value of ablative margin assessment after microwave ablation for local tumor progression in medium and large hepatocellular carcinoma: Computed tomography-computed tomography image fusion method versus side-by-side method. J Comput Assist Tomogr, 47(1): 31-37. [DOI:10.1097/RCT.0000000000001395]

11. Yi JS CG (2022) Application of ultrasound fusion imaging in thermal ablation of large hepatocellular carcinoma. Modern Medical Imagelogy, 31(12): 2322-2324.

12. Lan SR-XJW and Zhang YM-EA (2022) Guidance of real-time contrast-enhanced ultrasonography and 3D ultrasound fusion imaging for ablation area in patients with primary liver cancer during microwave ablation therapy. Journal of Practical Hepatology, 25(6): 889-892.

13. Kuo KL, Stenehjem D, Albright F, Ray S, Brixner D (2015) Treatment patterns and outcomes in patients with hepatocellular carcinoma stratified by stage-guided treatment categories. J Natl Compr Canc Netw, 13(8): 987-94. [DOI:10.6004/jnccn.2015.0119]

14. Hui M, Uppin SG, Uppin MS, et al. (2023) Hepatocellular carcinoma: A clinicopathological and immunohistochemical study of 116 cases from a tertiary care hospital in Southern India. Indian J Cancer, 60(2): 191-198. [DOI:10.4103/ijc.IJC_1004_19]

15. Zhu Y, Feng B, Cai W, et al. (2023) Prediction of microvascular invasion in solitary AFP-negative hepatocellular carcinoma ≤5 cm using a combination of imaging features and quantitative dual-layer spectral-detector CT parameters. Academic Radiology, (23): 1076-6332. [DOI:10.1016/j.acra.2023.02.015]

16. Chen L, Ruan S, Wang P, et al. (2023) Imaging features of primary hepatic sarcomatoid carcinoma: Differentiation from hepatocellular carcinoma and intrahepatic cholangiocarcinoma on CT: A preliminary study. Heliyon, 9(3): e14123. [DOI:10.1016/j.heliyon.2023.e14123]

17. Cha DI, Kang TW, Jeong WK, Kim JM, Choi GS, Joh JW, Yi NJ, Ahn SH (2024) Preoperative assessment of microvascular invasion risk using gadoxetate-enhanced MRI for predicting outcomes after liver transplantation for single hepatocellular carcinoma within the Milan criteria. Eur Radiol, 34(1): 498-508. [DOI:10.1007/s00330-023-09936-y]

18. Makino Y, Imai Y, Igura T, et al. (2012) Usefulness of the multimodality fusion imaging for the diagnosis and treatment of hepatocellular carcinoma. Dig Dis, 30(6): 580-7. [DOI:10.1159/000343070]

19. Dong Y, Wang WP, Mao F, Ji ZB, Huang BJ (2016) Application of imaging fusion combining contrast-enhanced ultrasound and magnetic resonance imaging in detection of hepatic cellular carcinomas undetectable by conventional ultrasound. J Gastroenterol Hepatol, 31(4): 822-8. [DOI:10.1111/jgh.13202]

20. Uraki J YK and Nakatsuka A TK (2004) Transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma invading the portal veins: therapeutic effects and prognostic factors. Eur J Radiol, 51(1): 12-18. [DOI:10.1016/S0720-048X(03)00219-5]

21. Wang L LB and Tian LF (2014) Multi-modal medical image fusion using the inter-scale and intra-scale dependencies between image shift-invariant shearlet coefficients. Information Fusion, 19: 20-28. [DOI:10.1016/j.inffus.2012.03.002]

22. Wu W JX, Xue GQ, et al. (2022) A multicenter randomized controlled study of contrast-enhanced US versus US-guided biopsy of focal liver lesions. Radiology, 305(3): 721-728. [DOI:10.1148/radiol.212317]

23. Zhang EL CQ and Huang ZY DW (2021) Revisiting surgical strategies for hepatocellular carcinoma with microvascular invasion. Front Oncol, 11: 691354. [DOI:10.3389/fonc.2021.691354]

24. Ayuso C RJ, Vilana R, et al. (2018) Diagnosis and staging of hepatocellular carcinoma (HCC): current guidelines. Eur J Radiol, 101(5): 72-81. [DOI:10.1016/j.ejrad.2018.01.025]

25. Akino Y, Oh RJ, Masai N, Shiomi H, Inoue T (2014) Evaluation of potential internal target volume of liver tumors using cine-MRI. Med Phys, 41(11): 111704. [DOI:10.1118/1.4896821]

26. Fernandes AT, Apisarnthanarax S, Yin L, et al. (2015) Comparative assessment of liver tumor motion using cine-magnetic resonance imaging versus 4-dimensional computed tomography. Int J Radiat Oncol Biol Phys, 91(5): 1034-40. [DOI:10.1016/j.ijrobp.2014.12.048]

27. Yang J, Wang H, Yin Y, Li D (2015) Retracted: Reducing motion artifacts in 4D MR images using principal component analysis (PCA) combined with linear polynomial fitting model. J Appl Clin Med Phys,16(2): 5165. [DOI:10.1120/jacmp.v16i2.5165]

28. Rennert J, Georgieva M, Schreyer AG, et al. (2011) Image fusion of contrast enhanced ultrasound (CEUS) with computed tomography (CT) or magnetic resonance imaging (MRI) using volume navigation for detection, characterization and planning of therapeutic interventions of liver tumors. Clin Hemorheol Microcirc, 49(1-4): 67-81. [DOI:10.3233/CH-2011-1458]

29. Xu E LY and Li K EA (2019) Comparison of CT/MRI-CEUS and US-CEUS fusion imaging techniques in the assessment of the thermal ablation of liver tumors. Int J Hyperthermia, 35(1): 159-167. [DOI:10.1080/02656736.2018.1487591]

30. Lima PH FB, Bérubé J, et al. (2019) Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma. Am J Roentgen, 213(1): 17-25. [DOI:10.2214/AJR.18.20341]